News & Updates
Filter by Specialty:
Biologic agents raise IBD risk among axSpA patients
08 Feb 2023
Based on observational studies, patients with axial spondyloarthritis (axSpA) treated with biologics are at higher risk of inflammatory bowel disease (IBD), while findings from randomized controlled trials (RCTs) suggest that treatment with etanercept (ETN) tends to increase such risk compared to other antitumour necrosis factor (anti-TNF) therapies, according to the result of a meta-analysis.
Biologic agents raise IBD risk among axSpA patients
08 Feb 2023
Obesity tied to gestational diabetes risk
08 Feb 2023
Obesity appears to exert a detrimental causal effect on the risk of gestational diabetes, with lipid metabolism acting as a potential driver of the relationship, according to the results of a Mendelian randomization analysis.